16
Perspective Ramez Shehadi Ali Hashemi Walid Tohme Jad Bitar Getting a Handle on Chronic Disease Health Management Services in the GCC Region

BoozCo Viewpoint Getting a Handle on Chronic Disease

Embed Size (px)

Citation preview

  • Perspective Ramez ShehadiAli HashemiWalid TohmeJad Bitar

    Getting a Handle on Chronic DiseaseHealth Management Services in the GCC Region

  • Booz & Company

    Contact Information

    BeirutRamez [email protected]

    Walid [email protected]

    Jad BitarSenior [email protected]

    DubaiAli [email protected]

  • Booz & Company 1

    EXECUTIVE SUMMARY

    HMS programs address critical gaps in the care of chronically ill patients by helping them understand the implications of their disease and underlying lifestyle factors, amend their harmful behavior, adhere to treatment regimens, and navigate the healthcare system. HMS programs have been proven to be successful at improving individuals health and generating significant savings for healthcare payors when all stakehold-erspatients, physicians, hospitals, insurers, and governmentbuy into their development. A number of best

    practicesincluding effective use of incentives, physician involvement, and personalizationcan help HMS pro-grams achieve their goals. But before GCC governments and healthcare organizations can implement HMS programs, they will need to answer strategic questions about the segments of society that should be targeted, the programs that will be most relevant, the incentives that would encourage involvement, the funding mechanism that will support HMS, the objec-tives of the program, and the roles of public and private entities.

    The growing prevalence of chronic diseases in Gulf Cooperation Council (GCC)1 nations has socioeconomic implications that are quickly adding up. Chronic diseases generate higher healthcare costs, which are borne by govern-ments, insurers, and patients. They also lower productivity among workers, clog healthcare service channels, and bring about declines in a populations health status. As GCC nations continue to invest in their healthcare systems, the regions leaders should take their cue from certain developed nations in adopting health management services (HMS) to help address the specter of a chronic disease epidemic.

  • Booz & Company

    Around the world, unhealthy lifestyles and aging populations are leading to a higher prevalence of chronic disease, thus driving up healthcare costs and keeping economies from perform-ing at their true potential. Chronic diseases strain healthcare providers and the overall healthcare system with patients frequent and costly trips to the emergency room (ER) and longer average stays. Long and resource-intensive treatment periods make patients with chronic disease heavy users of healthcare services, leading them to consume a dispropor-tionate amount of the total available services. This has a severe impact on the distribution of those services and clogs providers ER and other delivery channels.

    Chronic diseases not only negatively affect a populations general health status, but they also levy serious

    hidden costs on society, such as lower worker productivity. Recent research shows that on-the-job productivity losses account for up to 60 percent2 of the total healthcare costs associated with chronic diseases.

    To counter these trends, care provid-ers in North America are increasingly turning to health management services (HMS). These services primarily work in two ways: They help mitigate the spread of chronic diseases by estab-lishing wellness programs and other preventive strategies, and they reduce the costs of treating chronic diseases once they are diagnosed through ongoing monitoring and frequent interaction with patients.

    HMS will be a critical element of GCC countries overall healthcare strategies in the future, as chronic diseases exact a toll in terms of costs, strain on providers, and healthcare status: In the coming years, chronic diseases are expected to account for a significant portion of healthcare expenses. As governments, healthcare organizations, and private insurers in the region look to develop a compre-hensive health management strategy that addresses this mounting problem, HMS programs are a key tool.

    2

    THE RUNAWAY COSTS OF CHRONIC DISEASES

    KEY HIGHLIGHTS

    HMSprogramsareakeytoolinthe effort to halt the rise of chronic diseases in GCC countries and keephealthcarecostsincheck.

    NumerousstudieshavedemonstratedthebenefitsofHMSonindividualshealthand on overall healthcare cost management.

    HMSprogramsblendwellnessservices that provide healthy individuals with information and encouragementtobettermanagetheirhealthriskswithdiseasemanagementthatincreaseschronicallyillpatientscompliancewith prescribed treatments.

    EffectiveHMSprogramsarecharacterized by three common themes: incentives to ensure patientparticipation,strategiestoinvolvephysiciansaskeyprogramfacilitators, and communications and incentives that are tailored to individual preferences.

  • Booz & Company 3

    The rapid economic expansion of the GCC region has brought its member nations the benefits of advanced developed countrieshigher stan-dards of living, lower unemployment, and increased purchasing power. But along with such advantages also come new and pressing challenges, particularly in the realm of health-care. In recent years, GCC nations effectively combated typical third world health challenges such as tuberculosis and malaria. However, due to the rapid growth and develop-ment of the region and the resultant change in lifestyles, GCC leaders are now turning their attention to

    an increasing prevalence of chronic diseases among their citizenry.

    In the typical GCC country today, chronic diseases are a leading cause of mortality; in 2007, the region was home to four of the top five nations in the world for diabetes cases among adults (see Exhibit 1). Based on data available from several GCC geog-raphies, chronic diseases currently account for approximately 35 percent or more of the deaths in those regionsfast approaching levels in developed countries such as the U.S., where chronic diseases account for an estimated 70 percent of mortalities.

    A PRESSING PROBLEM FOR GCC NATIONS

    Exhibit 1 Prevalence of Chronic Diseases in the GCC Region

    Source:HAADstatistics;WorldHealthOrganization

    32%

    6%

    7%14%

    23%

    18%

    LEADING CAUSES OF DEATH IN ABU DHABI2007

    Nauru UAE

    16.7%

    SaudiArabia

    Bahrain Kuwait Oman Egypt USA

    PERCENTAGE OF ADULT POPULATION WITH DIABETES BY RANKING2007

    7.8%

    11.0%13.1%

    14.4%15.2%

    19.5%

    30.7%

    Accidents/Injury

    Cardiovascular

    Cancer

    Diabetes

    Congenital

    Other

  • Booz & Company4

    Lifestyle factors in the GCC region have contributed mightily to this scourge, setting the stage for the creation of a chronic disease epi-demic. Increasing affluence in GCC countries has caused a once highly active population to become largely sedentary, resulting in reduced levels of physical activity, increased smoking rates, and other unhealthy lifestyle changes. These changes are triggering heightened obesity rates and inci-dences of hypertension, key factors that contribute to chronic disease.

    Because many of these factors are not addressed before they mature into chronic diseases, GCC governments are being forced to dedicate more of their budgets to treat a growing wave of patients. In the UAE, where one in every five adults is afflicted with dia-betes, treatment of that illness alone takes up approximately 40 percent of the nations overall healthcare expen-ditures.3 The burden posed by chronic diseases weighs more heavily on GCC governments because they shoulder a greater share of healthcare expen-

    ditures than governments in other parts of the world. Public spending on healthcare averaged 74 percent in GCC countries in 2006, nearly 20 percentage points higher than the global average of 57 percent4 (see Exhibit 2). But the issue also looms large for the private insurance compa-nies that are entering GCC markets, which need to keep their costs down to remain competitive.

    Exhibit 2 GCC Governments Contribute Significantly More to Healthcare Costs Than the Global Average

    *HDI=HumanDevelopmentIndex;WorldAverageisbasedon177countries;Top30excludesHongKong,forwhichfigureswerenotavailable. Source: WHO Statistical Information System, 2006 data

    Publ

    ic E

    xpen

    ditu

    re a

    s a

    % o

    f Tot

    al H

    ealth

    care

    Exp

    endi

    ture

    Top 30 HDI* Average = 71%

    World Average* = 57%

    GCC Average = 74%

    SHARE OF PUBLIC EXPENDITURE IN HEALTHCARE 2006

    30%

    40%

    50%

    60%

    70%

    80%

    90%

    UnitedKingdom

    Japan Sweden France Germany Canada Australia Switzerland Republicof Korea

    UnitedStates ofAmerica

    China Oman Kuwait SaudiArabia

    Qatar UnitedArab

    Emirates

    Bahrain

  • Booz & Company 5

    Needless to say, the rising socioeco-nomic costs of chronic diseases have caught the attention of GCC govern-ments. Some have set up government bodies and programs to develop preventative healthcare strategies and address the low level of health aware-ness in the region. In many cases involving chronic diseases, consumers have little knowledge about preven-tion and management of their condi-tions. For instance, a study about osteoporosis among educated women in the UAE found that 44 percent of women with at least a secondary school education had minimal or zero knowledge of the disease.5

    To date, however, such government programs have not been able to fully address the escalating needs of the GCC regions large and grow-ing population of chronic disease sufferers. Post-diagnosis, chronic disease patients have a broad array of clinical and non-clinical needs associ-ated with managing their condition. Diabetics, for example, need to continually manage their disease, on top of identifying and changing the lifestyle factors that caused it. Their responsibilities include measuring blood glucose levels, taking insulin shots, and getting regular screenings and tests.

    Typically, chronically ill patients need assistance in four major elements of their disease management: under-standing the implications of their dis-ease, such as treatment options, risk factors, and potential complications; navigating the healthcare system and communicating with the various care providers, especially for patients with multiple chronic diseases who must make multiple visits; gathering information about the various actions they need to undertake, including self-care, dietary changes, and exer-cise; and complying with their care regimen, such as planning multiple provider visits and taking prescribed medicines.6

    Currently, though, such needs are filled only during formal physician visits or informally by other sources such as family and friends. These interactions only partially address a chronically ill patients continuous need for care advice, monitoring, and compliance. As such, critical gaps in care provision exist before, between, and after provider visits, particularly when it comes to identifying high-risk behavior, adhering to a treatment regimen, patient monitoring, and other elements of care coordination.

    ADDRESSING GAPS IN PATIENT CARE

  • Booz & Company6

    To close these gaps and improve the overall care of chronically ill patients, healthcare leaders in some developed economies are employing HMS, which bundle a prescribed set of healthcare services into condition-specific programs that are based on scientific evidence and data analysis. The healthcare services address the patients needs identified above: risk identification, awareness and education, adherence to treatment regimen, monitoring health indicators, and care coordination. The HMS program encourages individual members to improve their health by creating a support system that helps them manage their condition, increasing their awareness, providing critical guidance, and employing incentives to encourage healthy behavior. HMS also strengthen relationships between hospitals and their patients and physicians, by creating a continuous, longitudinal view of patient care that competitors cannot match.

    THE CASE FOR HMS

    FACTS AND FIGURES

    Obesity:GCCnationsarehometosomeofthehighestobesityratesintheworld. Thirty percent or more of the adult populations in Saudi Arabia, the UAE,Kuwait,andBahrainhaveabodymassindex(BMI)of30ormore,theclinicaldefinitionofobese.InAbuDhabi,theaverageBMIis29amongadults.i

    Smoking:GCCcountrieshavearelativelymoderatenumberofsmokers36percentversusaglobalaverageof33percent.Butonapercapitabasis,theirannualintakeofcigarettesismuchhigher,fueledbyhigherconsumptionamongyoungmales.Forexample,theaverageKuwaitismokerconsumesmorethan2,500cigarettesayear,comparedwithaworldwideaverageof900.

    Physical Inactivity: At least 40 percent of the GCC population fails to achieve the minimum daily recommendation of 30 minutes of moderate-intensity physicalactivity.Thisrateismorethandoubletheglobalestimateof17percent.ii

    Hypertension: ModernizationhasbeendirectlylinkedtohigherstresslevelsinGCCnations.Roughly34percentiii of the adult population in Abu Dhabi hashighbloodpressure,comparedwithjust18percentintheU.S.Statisticsalsorevealahighcorrelationbetweenhypertensionandtheoccurrenceofdiabetes.

  • 7Booz & Company 7Booz & Company

    As an example, diabetics enrolled in an HMS program designed to help manage their condition can expect the following services:

    Comprehensive diabetes plan including diet, medication, exercise, and screening

    Diabetes articles and the latest research on diabetes

    Coordination with provider

    Remote consultation and setting of appointments

    Diabetic community tools

    Glycemic index counter and low glycemic food guide

    Medication and screening test alerts

    Coaching and intervention-related services are at the core of HMS programs and they are typically conducted by a call center staffed by nurses. The call centers contact patients to provide them with vari-ous services based on the program in which the patient is enrolled (e.g., information on care regimen, reminders for screening, coordinat-ing physician visits). Through these coaching and intervention services, HMS provide consumers with the information and guidance required while coordinating care in order to help consumers manage their health and directly address the gaps in care provision.

    By supporting individuals in main-taining their health and helping chronic patients with their condi-tions, HMS programs have a direct impact on healthcare costs. Although

    such savings are often difficult to quantify, numerous studies have demonstrated the benefits of HMS on individuals health, as well as on overall healthcare costs. For instance, a study published in Health Affairs in 2004 showed an 8.1 percent drop in hospitalization costs of diabetes patients after they were enrolled in an HMS program to help manage their treatment.7 A separate finding published in 2005 in the European Journal of Public Health found that HMS smoking cessation programs resulted in a 15 percent to 35 percent quit rate, saving employers (here collectively referred to as payors) an average of US$11,880 per smoker over their lifetimes.8

    By supporting individuals in maintaining their health and helping chronic patients with their conditions, HMS programs have a direct impact on healthcare costs.

  • Booz & Company8

    Such success stories have led health insurance companies and payors to increasingly adopt these services as a way of controlling their soaring healthcare costs. The HMS industry has been growing significantly in early adopter markets such as the U.S., where it has enjoyed a com-pound annual growth rate of more than 25 percent over the past decade and now enjoys a penetration rate of 5 percent to 10 percent of total insured lives.9 In recent years, pilot HMS programs have begun to crop up in Latin America, Europe, and Asia. Payors especially have found these programs to be beneficial, due to their positive impact on employee productivity and satisfaction. Additionally, HMS programs are one of the few options available to payors that believe that prevention needs to be a key element of their healthcare cost containment strategy. A recent evolution in the HMS delivery model has been the integration of Internet-based platforms, while face-to-face coaching continues to be used to deliver interventions (see Health Management Goes Online).

    HEALTH MANAGEMENT GOES ONLINE

    HMSprovidersareincreasinglyleveragingtechnologytoconductdataanalytics,integrateremotemonitoringdevices,andleveragealternativeaccesschannels.Still,itwasntuntilrecentlythatHMSbeganmigratingtoInternet-basedplatforms.Traditionally,healthmanagementprogramsweredeliveredsolelythroughanurseoracoachanexpensivemediumforparlayingservices.Intheinterestofreducingcosts,providershavebeguneffectivelyincorporatingWeb-basedprogramsinconjunctionwithcoachesandnurse-staffedcallcenters.AnotheradvantagetoonlineHMSisitprovidesmoreleewaytopersonalizeprogramelements,whichevidenceshowsincreasespatientsparticipationinandcompliancewithHMSprograms.

    Citingtheseadvantages,leadingHMSprovidersaremakingacquisitionsandotherkeyinvestmentstoincorporateInternet-basedmodelsasakeyvehiclefordeliveringHMSprograms.Infact,certainleading-edgeprovidershaveintroducedprogramsthataredeliveredexclusivelyovertheInternet.LeadingHMScompanies,includingHealthwaysInc.andMatriaHealthcare,havemadenotableforaysintoonlineprogramdelivery.Healthwayshasmadesignificant,targetedinvestmentsinthisarea,mainlyfocusedonbuildinganinternaltechnologyteamthatcouldhelpitdeliveranonlineplatformforitsprograms,whileMatria,nowpartofAlereMedical,acquiredonlineHMSproviderWinningHabits.com.Conversely,leadinghealthcareportalssuchasWebMDandRevolutionHealthhavepurchasedcompaniestoaddHMSprogramstotheiralready popular Web services.

    HMS programs are one of the few options available to payors that believe that prevention needs to be a key element of their cost-containment strategy.

  • 9Booz & Company

    screenings and immunizations (e.g., flu shots), and share information to foster self-care practices. Follow-up support is provided by on-site, telephone-based, or online coaching assistance through condition-specific programs such as weight manage-ment, smoking cessation, and stress management.

    Disease-management programs offer a prospective, disease-specific approach to coordinating the care of high-cost and high-risk populations with chronic conditions, including dia-betes, asthma, and congestive heart failure. They typically involve a coor-dinated set of healthcare interven-tions and communications designed to support the patientphysician relationship by ensuring the patients compliance with the prescribed care plan. These programs focus on keeping conditions from being exacerbated, through co-morbidities or other complications, by using evidence-based practice guidelines and strategies to empower patients.

    Both types of HMS program are typically designed around four major components:

    Adoption focuses on understand-ing members or employees needs, evaluating patients risk profiles through health-risk appraisals, selecting the appropriate program and pricing strategy, and encourag-ing adoption through marketing efforts and enrollment incentives.

    Program delivery centers on core intervention elements that are designed to help the consumer manage his or her condition and reduce risk factors through a per-sonalized delivery strategy.

    Monitoring sets clear performance metrics, measures against them, and verifies desired outcomes.

    Improvement involves modifying the program elements to enhance the effectiveness of the program.

    HMS programs are broadly classified as either wellness programs or disease management programs. Whereas the latter deals with patients already afflicted with chronic diseases, the former aims to reduce risk fac-tors that cause the onset of chronic diseases in the first place through the pursuit of mental and physical well-being.

    Typical wellness programs provide healthy individuals with information, support, guidance, and encourage-ment to better manage their lifestyle-related health risks. First, health-risk assessments help assign consumers to various risk groups. Then providers institute preventive measures such as

    KEY COMPONENTS OF HMS PROGRAMS

  • Booz & Company10

    To be sure, health management is not an exact science, given that the success of these programs depends to a large extent on their ability to change behavior. The HMS industry is constantly innovating to develop new techniques to improve programs ability to ensure compliance, reduce risk factors, and carry out preventive screenings and thus deliver on their promised benefits. There are three key ingredients in successfully deployed HMS programs, all of which can be leveraged in GCC markets:

    Incentives: Well-designed HMS programs provide consumers with a variety of incentives to ensure partici-pation, such as reduced premiums, cash incentives, and redeemable reward points akin to points given by various reward programs. HMS programs are also using negative incentives such as higher premiums or co-pays for non-participants. Increasingly, programs are adopt-ing a combination of bothnegative incentives to ensure enrollment and positive incentives to effect behavioral change.

    Physician Involvement: Coordinating program interventions and other elements with the patients physi-cian is another critical facilitator in assuring program efficacy. In a case where drug adherence is identified as a problem, for instance, involving the physician isnt just about relat-ing critical information; it creates an opportunity for the physician to inter-vene and reinforce the importance of sticking to the drug regimen. Given the low level of health literacy and

    awareness of health issues in GCC countries, there is greater reliance on physicians by patients, making physician involvement all the more critical. HMS programs in the region will need to engage relevant physi-cian groups to obtain their buy-in and ensure their participation and involvement.

    Personalization: Tailoring com-munications and incentives to the individuals tastes and preferences is a new and evolving trend credited with increasing patient compliance with HMS programs. Participants receive personalized letters, educa-tional brochures, and booklets to increase awareness. Incentives and other aspects of the plans design are customized to adjust to the individual participants ability to change. HMS providers are building large databases of consumer information to document the success of interventions, incen-tives, and communications, and to leverage these large data warehouses to personalize their interactions with other members.

    The ways in which these building blocks are used will be determined by healthcare payors overall HMS strategy, which will require analysis, judgment, detailed design, and pilot-ing of alternative concepts, as well as allocation of significant resources for implementation. Payors will also likely require the involvement of lead-ing disease management and wellness companies from mature HMS mar-ketsprimarily the U.S.to ensure that the plan imperatives highlighted above are incorporated.

    PUTTING HMS INTO PRACTICE

  • 11Booz & Company

    To help jump-start the process and lay a sound foundation for successful implementation, GCC governments and healthcare organizations must assess their current overall healthcare strategy to address a number of stra-tegic questions:

    How should HMS programs be integrated into their current health-care strategic framework?

    Which segments of the population will be targeted? How will the pro-gram design be modified to address the cultural characteristics of the population?

    Which HMS programs would be most relevant for GCC populations?

    What incentives will be required to ensure significant program adop-tion among targeted segments?

    How will health management ser-vices be funded? How will the costs (and risks) be distributed among the various stakeholders?

    What would be the financial and health status objectives of HMS programs? Should GCC govern-ments support these programs if the financial return on investment is not clear but there is a positive impact on the health status of the population? What will be the role of healthcare providers and health insurance companies?

    Through which entity will the programs be offered? Will it be a publicprivate partnership between a GCC government and an interna-tional disease management/wellness company, or will it be an entirely private undertaking?

    What policy initiatives will be required to support HMS rollout?

    How will GCC governments ensure that other healthcare stakeholders, primarily providers, support the rollout of the HMS programs?

    What will be the role of e-health in delivering HMS to the population?

    CONCLUSION

  • Booz & Company12

    How will the execution of HMS programs be managed across various governmental authorities? What are the critical factors for the successful execution and rollout of HMS programs?

    Chronic disease management is an issue that GCC nations can ill afford to ignore. Countries that fail to address this pressing concern run a real risk of being engulfed in a chronic disease epidemic, resulting in reduced health status, crippling healthcare costs, lower workforce

    productivity, and immense strain on the healthcare system.

    Well-crafted HMS programs are a valuable tool that can help GCC nations stem the rising tide of chronic diseases by helping to identify unhealthy and risky behaviors, raise awareness of underlying lifestyle fac-tors, improve adherence to treatment regimens, and strengthen the bonds between patients and physicians. Now is an opportune time for GCC nations to adopt HMS programs as most GCC nations are undertak-

    ing significant investments in their healthcare systems. Indeed, rapid implementation of such programs is within grasp for smaller markets in the region.

    As GCC nations prime for a robust economic recovery, their leaders will need to put a premium on smart growth strategies. When it comes to managing the populations most serious and costly illnesses, there is no smarter healthcare strategy than HMS.

  • 13Booz & Company

    About the Authors

    Ramez Shehadi is a partner with Booz & Company in Beirut. He leads the informa-tiontechnologypracticeintheMiddleEast.Hespecializesine-government,e-business,andtechnology-enabledtransfor-mation,helpingbothprivatecorporationsandgovern-mentorganizationsleveragetechnology,achieveoperationalefficiencies,andimprovegovernance.

    Ali Hashemi is a principal with Booz & Company in Dubai and a leader in the healthcare practiceintheMiddleEast.He specializes in business strategyforplayersthroughoutthe healthcare value chain, as wellasadvisinggovernmententitiesondefiningtheiroverallhealthcareagendas.

    Walid Tohme is a principal with Booz & Company in Beirut and a leader in the information tech-nologypracticewithafocusonhealthcare. He specializes in themanagementandstrategicuseoftechnologytoenablethetransformation of healthcare organizations,services,andinfrastructure.

    Jad Bitar is a senior associate with Booz & Company in Beirut and a leader in the informa-tiontechnologypracticewitha focus on healthcare. He specializes in healthcare and businesstechnology,par-ticularlystrategy,organization,operations, and innovation.

    Endnotes

    1 The Gulf CooperationCouncilconsistsofBahrain,Kuwait,Oman,Qatar,SaudiArabia,andtheUnitedArabEmirates.2WHOMortalityFactSheetforSaudiArabia(2006)andQatarMinistryofHealthstatistics.3TreatmentofDiabetesaBigDrainonNationalHealthcareBud-get,Gulf News,November11,2007.4 WHO Statistical Information System, 2006 data.5HaiderM.AlAttia,AmalA.AbuMerhi,andMahaM.AlFarhan,HowMuchDotheArabFemalesKnowaboutOsteoporosis?TheScopeandtheSourcesofKnowledge,Clinical Rheumatology, vol. 27, no. 9, September 2008, 11671170. 6Apresumablysimpleelementofthecomplianceregimen,adherencetoprescribeddrugregimen,suffersfromalargenoncompliance rate.

    7 Victor G.VillagraandTamimAhmed,EffectivenessofaDiseaseManagementProgramforPatientswithDiabetes,Health Affairs, vol. 23, no. 4, 2004, 255266.8SusanneR.Rasmussen,EvaPrescott,ThorkildI.A.Srensen,andJesSgaard,TheTotalLifetimeHealthCostSavingsofSmokingCessationtoSociety,European Journal of Public Health, vol. 15, no. 6, December 2005.9 Booz & Company estimates.iHealthAuthorityAbuDhabi(HAAD)statistics.iiWorldHealthOrganizationandOxfordHealthAlliance;theratesforphysicalinactivityinUAEwereforthetopandbottomquintilesof income class.iii HAAD statistics.

  • 2009 Booz & Company Inc.

    Booz & Company is a leading global management consulting firm, helping the worlds top businesses, governments, and organizations. Our founder, Edwin Booz, defined the profession when he established the first management consulting firm in 1914.

    Today, with more than 3,300 people in 59 offices around the world, we bring foresight and knowledge, deep functional expertise, and a practical approach to building capabilities and delivering real impact. We work closely with our clients to create and deliver essential advantage.

    For our management magazine strategy+business, visit www.strategy-business.com. Visit www.booz.com to learn more about Booz & Company.

    The most recent list of ourofficeaddressesandtelephone numbers can be found on our website, www.booz.com

    Worldwide Offices

    AsiaBeijing DelhiHongKongMumbaiSeoulShanghaiTaipeiTokyo

    Australia, New Zealand & Southeast AsiaAdelaideAucklandBangkokBrisbaneCanberraJakartaKualaLumpurMelbourneSydney

    EuropeAmsterdamBerlinCopenhagen

    DublinDsseldorfFrankfurtHelsinkiLondonMadridMilanMoscowMunichOsloParisRomeStockholmStuttgartViennaWarsawZurich

    Middle EastAbu DhabiBeirutCairoDubaiRiyadh

    North AmericaAtlantaChicagoClevelandDallasDetroitFlorhamParkHoustonLosAngelesMcLean

    MexicoCityNewYorkCityParsippanySanFrancisco

    South AmericaBuenos AiresRio de JaneiroSantiagoSo Paulo